BLPH logo

Bellerophon Therapeutics (BLPH) Total Liabilities

Annual Total Liabilities

$5.40 M
+$145.00 K+2.76%

December 31, 2022


Summary


Performance

BLPH Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHbalance sheetmetrics:

Quarterly Total Liabilities

$1.26 M
-$4.37 M-77.66%

September 30, 2023


Summary


Performance

BLPH Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

BLPH Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.8%-75.8%
3 y3 years-43.3%-75.8%
5 y5 years-86.3%-93.6%

BLPH Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-2.7%-77.7%at low
5 y5-year-55.0%-2.7%-89.5%at low
alltimeall time-86.3%-2.7%-96.8%at low

Bellerophon Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2023
-
$1.26 M(-77.7%)
Jun 2023
-
$5.62 M(+4.8%)
Mar 2023
-
$5.36 M(-0.7%)
Dec 2022
$5.40 M(+2.8%)
$5.40 M(+4.3%)
Sep 2022
-
$5.18 M(-5.0%)
Jun 2022
-
$5.45 M(-2.2%)
Mar 2022
-
$5.58 M(+6.1%)
Dec 2021
$5.26 M(-56.2%)
$5.26 M(-4.9%)
Sep 2021
-
$5.52 M(-20.9%)
Jun 2021
-
$6.98 M(-23.0%)
Mar 2021
-
$9.06 M(-24.4%)
Dec 2020
$11.99 M(+26.0%)
$11.99 M(+7.4%)
Sep 2020
-
$11.17 M(+20.7%)
Jun 2020
-
$9.25 M(-1.9%)
Mar 2020
-
$9.43 M(-0.9%)
Dec 2019
$9.52 M(-34.4%)
$9.52 M(+2.8%)
Sep 2019
-
$9.26 M(+1.6%)
Jun 2019
-
$9.12 M(-37.1%)
Mar 2019
-
$14.49 M(-0.1%)
DateAnnualQuarterly
Dec 2018
$14.50 M(-63.2%)
$14.50 M(-26.4%)
Sep 2018
-
$19.71 M(-47.6%)
Jun 2018
-
$37.59 M(+11.6%)
Mar 2018
-
$33.67 M(-14.5%)
Dec 2017
$39.40 M(+236.5%)
$39.40 M(+56.4%)
Sep 2017
-
$25.20 M(+8.9%)
Jun 2017
-
$23.14 M(-7.3%)
Mar 2017
-
$24.96 M(+113.2%)
Dec 2016
$11.71 M(+45.1%)
$11.71 M(+144.6%)
Sep 2016
-
$4.79 M(-22.9%)
Jun 2016
-
$6.21 M(-15.2%)
Mar 2016
-
$7.32 M(-9.3%)
Dec 2015
$8.07 M(-22.8%)
$8.07 M(-6.6%)
Sep 2015
-
$8.64 M(-22.5%)
Jun 2015
-
$11.15 M(-12.8%)
Mar 2015
-
$12.79 M(+22.3%)
Dec 2014
$10.45 M(-46.0%)
$10.45 M(-22.8%)
Sep 2014
-
$13.53 M(-30.1%)
Dec 2013
$19.37 M(+33.9%)
$19.37 M
Dec 2012
$14.46 M
-

FAQ

  • What is Bellerophon Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual total liabilities year-on-year change?
  • What is Bellerophon Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly total liabilities year-on-year change?

What is Bellerophon Therapeutics annual total liabilities?

The current annual total liabilities of BLPH is $5.40 M

What is the all time high annual total liabilities for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual total liabilities is $39.40 M

What is Bellerophon Therapeutics annual total liabilities year-on-year change?

Over the past year, BLPH annual total liabilities has changed by +$145.00 K (+2.76%)

What is Bellerophon Therapeutics quarterly total liabilities?

The current quarterly total liabilities of BLPH is $1.26 M

What is the all time high quarterly total liabilities for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly total liabilities is $39.40 M

What is Bellerophon Therapeutics quarterly total liabilities year-on-year change?

Over the past year, BLPH quarterly total liabilities has changed by -$3.92 M (-75.75%)